David Ryan, MD
Chief, Hematology-Oncology
Masscahusetts General Hospital
Disclosure(s): Bioimpact Capital: Consultant (Ongoing), Ownership Interest (Ongoing); Exact Sciences/Genomic Health: Consultant (Ongoing), Ownership Interest (Ongoing); McGraw Hill: Royalties (Ongoing); MPM Capital: Consultant (Ongoing), Ownership Interest (Ongoing); UptoDate: Consultant (Ongoing)